乳腺疾病的临床试验
总计379764个结果
-
Abramson Cancer Center at Penn Medicine招聘中
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company招聘中
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.招聘中
-
Imperial College LondonMedical Research Council; ECMC招聘中
-
University of MichiganNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的
-
Acrotech Biopharma Inc.完全的
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia; Hospital... 和其他合作者完全的
-
Fudan University未知
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey终止
-
Infinity Pharmaceuticals, Inc.终止
-
Case Comprehensive Cancer Center撤销I期乳腺癌 | HER2阳性乳腺癌 | 男性乳腺癌 | II期乳腺癌 | 雌激素受体阴性乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阴性乳腺癌 | 孕激素受体阳性乳腺癌 | HER2 阴性乳腺癌 | 乳腺导管原位癌 | 浸润性小叶乳腺癌 | 浸润性导管癌 | 伴有淋巴细胞浸润的髓样导管癌 | 粘液性导管乳腺癌 | 乳头状导管癌 | 管状导管癌美国
-
Swiss Group for Clinical Cancer Research尚未招聘
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Breast Cancer Foundation招聘中
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo招聘中晚期乳腺癌 | HER2阳性转移性乳腺癌 | 乳腺癌转移 | HER2低位乳腺癌法国
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative Breast Cancer...完全的
-
BioPharmX, Inc.完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)完全的0 期乳腺癌 | I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌美国
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.招聘中
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt Ltd招聘中
-
Karolinska University Hospital招聘中
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., Ltd招聘中
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex Therapeutics招聘中
-
Peter MacCallum Cancer Centre, Australia招聘中
-
Novartis Pharmaceuticals终止
-
Calithera Biosciences, Inc完全的
-
Veru Inc.撤销
-
Istituto Scientifico Romagnolo per lo Studio e...Agenzia Italiana del Farmaco未知
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
National Cancer Institute (NCI)完全的
-
University of WashingtonUnited States Department of Defense; Breast Cancer Alliance主动,不招人IV 期乳腺癌 | 复发性乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | III期乳腺癌 | HER2 阴性乳腺癌美国
-
George W. Sledge Jr.National Cancer Institute (NCI)完全的IV 期乳腺癌 | 复发性乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | HER2阳性乳腺癌 | III期乳腺癌美国
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)完全的
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人IV 期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 浸润性乳腺癌 | IIIC期乳腺癌 | HER2/Neu 阴性 | III期乳腺癌 | 绝经后 | 雌激素受体状态美国
-
Hebei Medical University Fourth Hospital招聘中
-
Spanish Breast Cancer Research GroupAstraZeneca招聘中
-
Institut fuer FrauengesundheitSamsung Bioepis Co., Ltd.招聘中
-
Saint Luke's Health SystemNovartis Pharmaceuticals招聘中
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave Roussy, Cancer... 和其他合作者招聘中HER2 阴性乳腺癌 | ER+乳腺癌英国, 法国